Microbio Co Ltd (4128) - Total Liabilities
Based on the latest financial reports, Microbio Co Ltd (4128) has total liabilities worth NT$2.11 Billion TWD (≈ $66.47 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Microbio Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Microbio Co Ltd - Total Liabilities Trend (2006–2025)
This chart illustrates how Microbio Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Microbio Co Ltd asset portfolio.
Microbio Co Ltd Competitors by Total Liabilities
The table below lists competitors of Microbio Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Western New England Bancorp Inc
NASDAQ:WNEB
|
USA | $2.48 Billion |
|
Compucase Enterprise Co Ltd
TW:3032
|
Taiwan | NT$14.44 Billion |
|
Dharma Polimetal Tbk PT
JK:DRMA
|
Indonesia | Rp1.55 Trillion |
|
Keyfield International Berhad
KLSE:5321
|
Malaysia | RM395.05 Million |
|
Hefei Jingsong Intelligent Technology Co. Ltd. A
SHG:688251
|
China | CN¥763.09 Million |
|
Hongda High-Tech Holding Co Ltd
SHE:002144
|
China | CN¥173.92 Million |
|
Orient Cement Limited
NSE:ORIENTCEM
|
India | Rs9.01 Billion |
|
Novabase SGPS
LS:NBA
|
Portugal | €67.20 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Microbio Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Microbio Co Ltd (4128) balance sheet quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Microbio Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Microbio Co Ltd (2006–2025)
The table below shows the annual total liabilities of Microbio Co Ltd from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$2.13 Billion ≈ $67.09 Million |
+3.47% |
| 2024-12-31 | NT$2.06 Billion ≈ $64.84 Million |
+66.68% |
| 2023-12-31 | NT$1.23 Billion ≈ $38.90 Million |
+14.07% |
| 2022-12-31 | NT$1.08 Billion ≈ $34.10 Million |
-7.73% |
| 2021-12-31 | NT$1.17 Billion ≈ $36.96 Million |
+9.28% |
| 2020-12-31 | NT$1.07 Billion ≈ $33.82 Million |
+6.37% |
| 2019-12-31 | NT$1.01 Billion ≈ $31.79 Million |
+81.80% |
| 2018-12-31 | NT$555.11 Million ≈ $17.49 Million |
-35.41% |
| 2017-12-31 | NT$859.50 Million ≈ $27.08 Million |
+1.82% |
| 2016-12-31 | NT$844.17 Million ≈ $26.60 Million |
-5.09% |
| 2015-12-31 | NT$889.40 Million ≈ $28.02 Million |
+37.71% |
| 2014-12-31 | NT$645.86 Million ≈ $20.35 Million |
-22.56% |
| 2013-12-31 | NT$834.06 Million ≈ $26.28 Million |
-11.50% |
| 2012-12-31 | NT$942.47 Million ≈ $29.69 Million |
+128.87% |
| 2011-12-31 | NT$411.80 Million ≈ $12.97 Million |
-16.71% |
| 2010-12-31 | NT$494.42 Million ≈ $15.58 Million |
-22.59% |
| 2009-12-31 | NT$638.68 Million ≈ $20.12 Million |
+34.81% |
| 2008-12-31 | NT$473.77 Million ≈ $14.93 Million |
+6.83% |
| 2007-12-31 | NT$443.47 Million ≈ $13.97 Million |
+83.42% |
| 2006-12-31 | NT$241.78 Million ≈ $7.62 Million |
-- |
About Microbio Co Ltd
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and health foods in Taiwan. It provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. The company is also involved in the sale of organic food and beverages; provision of te… Read more